We are live on ! Find out more
IDXX icon

Idexx Laboratories

613 hedge funds and large institutions have $11.9B invested in Idexx Laboratories in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 162 increasing their positions, 265 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 36

7% more funds holding

Funds holding: 573613 (+40)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

7% less capital invested

Capital invested by funds: $12.8B → $11.9B (-$902M)

16.3% less ownership

Funds ownership: 103.58%87.28% (-16%)

39% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 265

49% less call options, than puts

Call options by funds: $16.5M | Put options by funds: $32.3M

Holders
613
Holders Change
+40
Holders Change %
+6.98%
% of All Funds
13.9%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.34%
New
79
Increased
162
Reduced
265
Closed
36
Calls
$16.5M
Puts
$32.3M
Net Calls
-$15.8M
Net Calls Change
-$13.3M
Name Holding Trade Value Shares
Change
Change in
Stake
NMERB
301
New Mexico Educational Retirement Board
New Mexico
$1.31M +$31.5K +200 +2%
MLL
302
Moody Lynn & Lieberson
Massachusetts
$1.31M
SAM
303
Summit Asset Management
Tennessee
$1.29M -$31.5K -200 -2%
Nomura Holdings
304
Nomura Holdings
Japan
$1.23M -$96.6K -614 -7%
COPPSERS
305
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.22M +$111K +704 +10%
QI
306
QS Investors
New York
$1.21M +$373K +2,367 +44%
PA
307
Profund Advisors
Maryland
$1.21M -$161K -1,023 -12%
GC
308
Grimes & Company
Massachusetts
$1.2M
WAM
309
World Asset Management
Michigan
$1.2M -$100K -635 -8%
KJHP
310
K.J. Harrison & Partners
Ontario, Canada
$1.17M +$787K +5,000 +200%
EHWM
311
Eads & Heald Wealth Management
Georgia
$1.17M +$4.72K +30 +0.4%
GCP
312
GSA Capital Partners
United Kingdom
$1.16M -$517K -3,283 -31%
LTFS
313
Ladenburg Thalmann Financial Services
Florida
$1.16M +$100K +635 +9%
MCIM
314
Meadow Creek Investment Management
Georgia
$1.15M -$868K -5,516 -43%
AAM
315
Aureus Asset Management
Massachusetts
$1.11M -$40.9K -260 -4%
CI
316
Capital International
California
$1.11M +$1.11M +7,082 New
GIA
317
Gateway Investment Advisers
Ohio
$1.1M -$126K -799 -10%
ZIM
318
Zacks Investment Management
Illinois
$1.1M +$163K +1,037 +17%
CA
319
Commerzbank Aktiengesellschaft
Germany
$1.09M +$487K +3,093 +79%
BCM
320
BlueCrest Capital Management
Jersey
$1.09M -$994K -6,312 -48%
SIM
321
Sentry Investment Management
Wisconsin
$1.09M +$1.09M +6,945 New
SCM
322
Shelton Capital Management
Colorado
$1.08M
Twin Tree Management
323
Twin Tree Management
Texas
$1.08M -$1.89M -12,016 -64%
OAM
324
Oppenheimer Asset Management
New York
$1.05M
TAM
325
Tocqueville Asset Management
New York
$1.04M -$212K -1,350 -17%

IDXX Hedge Fund Activity: Q4 2017 in Review

613 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2017, worth a combined $11.9B — down 7.1% from $12.8B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new IDXX positions and 36 closed out — a net gain of 43 holders — while 162 added to existing stakes and 265 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $78.8M. The largest seller was Fundsmith LLP, cutting an estimated $2.22B.

  • 613 institutional investors held Idexx Laboratories (IDXX) as of Q4 2017, up from 573 in Q3 2017.
  • Funds reported $11.9B of Idexx Laboratories stock for Q4 2017, down 7.1% quarter-over-quarter.
  • 79 funds opened new Idexx Laboratories positions in Q4 2017 and 36 closed out, a net change of +43 holders.
  • The largest Idexx Laboratories buyer in Q4 2017 was William Blair Investment Management, an estimated $78.8M added.
  • The largest Idexx Laboratories seller in Q4 2017 was Fundsmith LLP, an estimated $2.22B sold.

Based on aggregated 13F filings for Q4 2017.